The Study of Quadruple Therapy Quercetin, Zinc, Metformin, and EGCG as Adjuvant Therapy for Early, Metastatic Breast Cancer and Triple-negative Breast Cancer, a Novel Mechanism

NCT05680662 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

UNKNOWN

Status

200

Enrollment

OTHER_GOV

Sponsor class

Conditions

Breast Cancer Female
Triple Negative Breast Cancer

Interventions

COMBINATION_PRODUCT: quercetin, EGCG, metformin , zinc

Sponsor

Ministry of Health, Saudi Arabia